vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Madison Square Garden Sports Corp. (MSGS). Click either name above to swap in a different company.

Madison Square Garden Sports Corp. is the larger business by last-quarter revenue ($403.4M vs $270.8M, roughly 1.5× HUTCHMED (China) Ltd). Madison Square Garden Sports Corp. runs the higher net margin — 2.0% vs 0.7%, a 1.3% gap on every dollar of revenue. On growth, Madison Square Garden Sports Corp. posted the faster year-over-year revenue change (12.8% vs -16.5%). Madison Square Garden Sports Corp. produced more free cash flow last quarter ($31.6M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

HCM vs MSGS — Head-to-Head

Bigger by revenue
MSGS
MSGS
1.5× larger
MSGS
$403.4M
$270.8M
HCM
Growing faster (revenue YoY)
MSGS
MSGS
+29.3% gap
MSGS
12.8%
-16.5%
HCM
Higher net margin
MSGS
MSGS
1.3% more per $
MSGS
2.0%
0.7%
HCM
More free cash flow
MSGS
MSGS
$28.2M more FCF
MSGS
$31.6M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HCM
HCM
MSGS
MSGS
Revenue
$270.8M
$403.4M
Net Profit
$2.0M
$8.2M
Gross Margin
37.7%
Operating Margin
-13.2%
5.5%
Net Margin
0.7%
2.0%
Revenue YoY
-16.5%
12.8%
Net Profit YoY
-83.6%
641.9%
EPS (diluted)
$0.00
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
MSGS
MSGS
Q4 25
$270.8M
$403.4M
Q3 25
$39.5M
Q2 25
$277.7M
$204.0M
Q1 25
$324.5M
$424.2M
Q4 24
$357.8M
Q3 24
$53.3M
Q2 24
$305.7M
$227.3M
Q1 24
$430.0M
Net Profit
HCM
HCM
MSGS
MSGS
Q4 25
$2.0M
$8.2M
Q3 25
$-8.8M
Q2 25
$455.0M
$-1.8M
Q1 25
$11.9M
$-14.2M
Q4 24
$1.1M
Q3 24
$-7.5M
Q2 24
$25.8M
$25.5M
Q1 24
$37.9M
Gross Margin
HCM
HCM
MSGS
MSGS
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
MSGS
MSGS
Q4 25
-13.2%
5.5%
Q3 25
-69.5%
Q2 25
-1.3%
-11.1%
Q1 25
-5.0%
7.6%
Q4 24
3.7%
Q3 24
-15.5%
Q2 24
-9.0%
23.0%
Q1 24
18.5%
Net Margin
HCM
HCM
MSGS
MSGS
Q4 25
0.7%
2.0%
Q3 25
-22.3%
Q2 25
163.8%
-0.9%
Q1 25
3.7%
-3.4%
Q4 24
0.3%
Q3 24
-14.1%
Q2 24
8.4%
11.2%
Q1 24
8.8%
EPS (diluted)
HCM
HCM
MSGS
MSGS
Q4 25
$0.00
$0.34
Q3 25
$-0.37
Q2 25
$0.52
$-0.08
Q1 25
$0.01
$-0.59
Q4 24
$0.05
Q3 24
$-0.31
Q2 24
$0.03
$1.07
Q1 24
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
MSGS
MSGS
Cash + ST InvestmentsLiquidity on hand
$1.4B
$81.3M
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$1.2B
$-282.1M
Total Assets
$1.8B
$1.5B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
MSGS
MSGS
Q4 25
$1.4B
$81.3M
Q3 25
$48.6M
Q2 25
$1.4B
$144.6M
Q1 25
$836.1M
$96.5M
Q4 24
$107.8M
Q3 24
$52.3M
Q2 24
$802.5M
$89.1M
Q1 24
$40.0M
Total Debt
HCM
HCM
MSGS
MSGS
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
HCM
HCM
MSGS
MSGS
Q4 25
$1.2B
$-282.1M
Q3 25
$-294.2M
Q2 25
$1.2B
$-281.4M
Q1 25
$759.9M
$-283.4M
Q4 24
$-273.1M
Q3 24
$-277.5M
Q2 24
$740.1M
$-266.3M
Q1 24
$-294.0M
Total Assets
HCM
HCM
MSGS
MSGS
Q4 25
$1.8B
$1.5B
Q3 25
$1.5B
Q2 25
$1.8B
$1.5B
Q1 25
$1.3B
$1.5B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.3B
$1.3B
Q1 24
$1.4B
Debt / Equity
HCM
HCM
MSGS
MSGS
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
MSGS
MSGS
Operating Cash FlowLast quarter
$8.2M
$32.4M
Free Cash FlowOCF − Capex
$3.4M
$31.6M
FCF MarginFCF / Revenue
1.2%
7.8%
Capex IntensityCapex / Revenue
1.8%
0.2%
Cash ConversionOCF / Net Profit
4.21×
3.94×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$-480.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
MSGS
MSGS
Q4 25
$8.2M
$32.4M
Q3 25
$-85.0M
Q2 25
$-72.9M
$49.7M
Q1 25
$40.3M
$6.3M
Q4 24
$61.8M
Q3 24
$-26.2M
Q2 24
$-39.8M
$108.4M
Q1 24
$4.0M
Free Cash Flow
HCM
HCM
MSGS
MSGS
Q4 25
$3.4M
$31.6M
Q3 25
$-85.3M
Q2 25
$-82.2M
$49.4M
Q1 25
$32.5M
$3.9M
Q4 24
$61.2M
Q3 24
$-26.5M
Q2 24
$-49.9M
$108.0M
Q1 24
$3.9M
FCF Margin
HCM
HCM
MSGS
MSGS
Q4 25
1.2%
7.8%
Q3 25
-216.3%
Q2 25
-29.6%
24.2%
Q1 25
10.0%
0.9%
Q4 24
17.1%
Q3 24
-49.7%
Q2 24
-16.3%
47.5%
Q1 24
0.9%
Capex Intensity
HCM
HCM
MSGS
MSGS
Q4 25
1.8%
0.2%
Q3 25
0.9%
Q2 25
3.3%
0.2%
Q1 25
2.4%
0.6%
Q4 24
0.1%
Q3 24
0.7%
Q2 24
3.3%
0.2%
Q1 24
0.0%
Cash Conversion
HCM
HCM
MSGS
MSGS
Q4 25
4.21×
3.94×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
55.61×
Q3 24
Q2 24
-1.54×
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

Related Comparisons